Pro Share Advisors LLC Citius Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.58 - $1.03 $3,566 - $6,334	-6,150 Reduced 25.45%	18,019 $10,000
Q1 2024 May 08, 2024	BUY	$0.6 - $0.9 $2,297 - $3,446	3,829 Added 18.82%	24,169 $21,000
Q4 2023 Feb 14, 2024	BUY	$0.65 - $0.86 $2,843 - $3,762	4,375 Added 27.4%	20,340 $15,000
Q3 2023 Nov 13, 2023	SELL	$0.65 - $1.25 $11 - $22	-18 Reduced 0.11%	15,965 $10,000
Q2 2023 Aug 10, 2023	BUY	$1.08 - $1.65 $17,261 - $26,371	15,983 New	15,983 $19,000
Q2 2022 Aug 01, 2022	SELL	$0.88 - $1.87 $20,443 - $43,441	-23,231 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$1.38 - $1.89 $2,172 - $2,974	-1,574 Reduced 6.35%	23,231 $42,000
Q4 2021 Feb 08, 2022	BUY	$1.51 - $2.2 $15,485 - $22,561	10,255 Added 70.48%	24,805 $38,000
Q3 2021 Nov 12, 2021	SELL	$1.74 - $2.6 $25,941 - $38,763	-14,909 Reduced 50.61%	14,550 $30,000
Q2 2021 Aug 13, 2021	BUY	$1.51 - $4.23 $44,483 - $124,611	29,459 New	29,459 $103,000

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $378M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.